Five Lives is a technology company.
Five Lives has raised $4.0M across 1 funding round.
Five Lives has raised $4.0M in total across 1 funding round.
Five Lives has raised $4.0M in total across 1 funding round.
Five Lives's investors include Christian Leybold, Headline (formerly e.ventures), INKEF Capital.
Five Lives is a digital therapeutics company developing a direct-to-consumer mobile app that helps users measure and reduce dementia risk through lifestyle improvements.[1][2][3][6] The app targets individuals aged 50-60+, particularly those over 60, by focusing on five key lifestyle pillars—nutrition, sleep, physical activity, mood & social connections, and mental stimulation—to support memory, autonomy, and brain health.[3][4][6] It serves everyday consumers concerned about cognitive decline, solving the problem of poor, lengthy, expensive, and inaccurate early dementia detection by offering an accessible, evidence-based tool approved as a medical device, created with research memory centers in the UK and France.[3][6] Founded in 2019 and previously known as SharpTx, the company has raised approximately $3.95M in funding from investors like Innovate UK, Headline, Speedinvest, and others, with growth including accelerator programs and plans for market expansion.[1][2][5]
Five Lives was founded in 2019 in London, UK, with additional bases in Tours, France, by Xavier Louis and Sylvain, both driven by personal and professional motivations to tackle dementia prevention.[1][3][4] Xavier, a serial entrepreneur from Aix-en-Provence, France, previously co-founded and led Peak (the No. 1 brain training app, exited in 2016) as CEO, bringing 15+ years in product management; he received Best French Tech Entrepreneur Abroad awards in 2016 and 2019 and carries the ApoE4 gene, a key Alzheimer's risk factor.[1][4] Sylvain contributes 20+ years in technology, focusing on operations, enterprise sales, and digital marketing, including as former COO at Peak.[4] Raised in medical families and leveraging tech expertise, they aimed to create purposeful tools for one of the 21st century's biggest health challenges: Alzheimer's and cognitive decline.[4] Early traction included Innovate UK Smart Grants in 2020/21 and app approval as a medical device, with the company rebranding from SharpTx.[1][3]
Five Lives rides the wave of digital therapeutics and preventive brain health tech, addressing the global dementia crisis—expected to affect millions amid aging populations—where early detection remains inadequate.[3][4][6] Timing aligns with rising demand for consumer-facing health apps post-COVID, accelerated by AI/healthtech investments and awareness of modifiable lifestyle risks (e.g., 40% of dementia cases preventable per research).[6] Market forces like insurtech accelerators (e.g., Plug and Play) and VC backing (Headline, Google for Startups) favor scalable D2C models over clinic-bound solutions, positioning it against competitors like Memodio by prioritizing user autonomy and family involvement indirectly through lifestyle focus.[5] It influences the ecosystem by advancing responsive digital tools for CNS disorders, complementing pharma via partnerships (e.g., 5-HT events), and expanding to markets like France/Germany, potentially democratizing brain health prevention.[3]
Five Lives is poised for scale with its clinically validated app addressing a massive, underserved need in dementia prevention, backed by $3.95M funding and accelerator momentum.[2][5] Next steps likely include completing Series A (targeted post-2022 plans), launching in France and Germany, and growing its remote team amid AI-driven health personalization trends.[3][5] Evolving regulations for digital therapeutics, aging demographics, and pharma collaborations will shape its path, potentially amplifying influence through global reach and data-driven insights—turning early risk detection into widespread brain health empowerment, much like Peak did for training.[4]
Five Lives has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Seed in November 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2022 | $4.0M Seed | Christian Leybold, Headline (formerly e.ventures), INKEF Capital |